DNMT1 and cancer: To test this, OXPHOS inhibition‐sensitive (NCI‐H82 and MDA‐MB‐453) and resistant (CFPAC‐1 and NCI‐H82‐OE‐NNMT/sh‐DNMT1) cancer cells are subcutaneously injected into flanks of nude mice.